Showing results (491-500 of 543) with videos related to
Sort By:
Pageof 55
Diabetes Care|September 28, 2002
Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetesFrancesco Chiarelli, Francesco Cipollone, Angelika Mohn, et al.Acta Neurologica Scandinavica|September 17, 2009
Levetiracetam monotherapy for childhood occipital epilepsy of gastautA Verrotti, P Parisi, G Loiacono, et al.Rheumatology International|February 19, 2025
Pediatric rheumatology on social media: experts ensure accuracy, public drives engagement - a comparative analysisSaverio La Bella, Marina Attanasi, Armando Di Ludovico, et al.European Journal of Clinical Investigation|March 16, 2002
Serum angiogenin concentrations in young patients with diabetes mellitusF Chiarelli, M Pomilio, A Mohn, et al.Journal of Cell Science|September 25, 2025
Charcot-Marie-Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell deathMariana Joaquim, Maria-Bianca Bulimaga, Marie A Mohn, et al.Wiener Klinische Wochenschrift|January 1, 1996
Evaluation of Cyfra 21-1 as a marker for lung cancerC Najemnik, A Mohn-Staudner, H Vetter, et al.Circulation|August 13, 2003
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic controlFrancesco Cipollone, Annalisa Iezzi, Maria Fazia, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 14, 2006
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetesChiara Cuccurullo, Annalisa Iezzi, Maria Luigia Fazia, et al.Journal of Pharmaceutical Sciences|May 2, 2009
Heterogeneity of commercial recombinant human growth hormone (r-hGH) preparations containing a thioether variantMonica Lispi, Antonio Datola, Horst Bierau, et al.European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC): a phase I trialG Krajnik, W Wein, R Greil, et al.Pageof 55